BiomeBank is a clinical stage biotechnology company developing microbial therapies
BiomeBank is a clinical stage biotechnology company developing a Pipeline of live biotherapeutic products to treat disease. BiomeBank's mission is to treat and prevent disease by replenishing gut microbial ecology. We currently provide BiomeBoost, a drug product which contains a broad-spectrum of microbes, for treatment of recurrent Clostridioides difficile.
BiomeBank has a world leading team of translational microbiome experts. Our Platform uses a unique combination of machine learning and microbiology to identify bacterial strains which influence disease. We use this to discover and develop microbial therapies.
